GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avecho Biotechnology Ltd (OTCPK:AVEFF) » Definitions » Accounts Payable

AVEFF (Avecho Biotechnology) Accounts Payable : $0.65 Mil (As of Jun. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Avecho Biotechnology Accounts Payable?

Avecho Biotechnology's Accounts Payable for the quarter that ended in Jun. 2024 was $0.65 Mil.

Avecho Biotechnology's quarterly Accounts Payable declined from Jun. 2023 ($0.73 Mil) to Dec. 2023 ($0.06 Mil) but then increased from Dec. 2023 ($0.06 Mil) to Jun. 2024 ($0.65 Mil).

Avecho Biotechnology's annual Accounts Payable increased from Dec. 2021 ($0.05 Mil) to Dec. 2022 ($0.13 Mil) but then declined from Dec. 2022 ($0.13 Mil) to Dec. 2023 ($0.06 Mil).

Avecho Biotechnology Accounts Payable Historical Data

The historical data trend for Avecho Biotechnology's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avecho Biotechnology Accounts Payable Chart

Avecho Biotechnology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.08 0.05 0.13 0.06

Avecho Biotechnology Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.13 0.73 0.06 0.65

Avecho Biotechnology Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Avecho Biotechnology Accounts Payable Related Terms

Thank you for viewing the detailed overview of Avecho Biotechnology's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Avecho Biotechnology Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avecho Biotechnology Ltd (OTCPK:AVEFF) » Definitions » Accounts Payable
Comparable Companies
ASX:CMB ASX:IXC ASX:ZLD ASX:NSB ASX:BGT ASX:VBS ASX:CHM ASX:PAB ASX:MEM ASX:ANR VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
OEZ:Germany AVE:Australia
Address
Unit A8, 2A Westall Road, Clayton, Melbourne, VIC, AUS, 3168
Website
https://www.avecho.com.au
Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sales, and licensing of products incorporating its patented platform technology TPM, for the pharmaceutical, skincare and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches including the conduct of research and development activities. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.

Avecho Biotechnology Headlines

No Headlines